Curi Bio is a pioneering brand that aims to accelerate the discovery of next-generation human medicines. They achieve this by integrating human cells, systems, and data. With a focus on biosystem platforms and models, Curi Bio offers a wide range of products and services.

Their biosystem platforms include Mantarray™, offering 3D tissue contractility analysis, Nautilus™ for optical mapping of voltage and calcium, Cytostretcher™ for cell stretching instruments, and NanoSurface™ Plates for structural maturation. Additionally, they provide data analytics platforms such as Pulse™, which offers high-throughput video contractility analysis software. Curi Bio's models encompass skeletal muscle models, cardiac models, disease models, and cells and media.

They offer MantaReady™ 3D skeletal muscle tissue media, MantaReady™ skeletal muscle myoblasts, and Celogics Celo. Cardiomyocytes. With their Curi Engine™ services, Curi Bio further enhances their offerings.

Customers can access product literature, application notes, peer-reviewed publications, video and webinars, and a knowledge base. Driven by a mission to revolutionize medicine, Curi Bio is led by an experienced management team and also benefits from the guidance of a scientific advisory board that includes renowned experts from Johns Hopkins University. Discover the future of medicine with Curi Bio